Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.

about

Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma.

P2860

Q33850074-24B0FE46-5F3E-4B1A-9710-9A7A15826885 Q41346357-E394A75C-0069-4377-A272-60B436C6B4B5

P2860

Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q41752588

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Overexpression of lymphoid enh ...... acute lymphoblastic leukemia.

@en

type

Item

label

Overexpression of lymphoid enh ...... acute lymphoblastic leukemia.

@en

prefLabel

Overexpression of lymphoid enh ...... acute lymphoblastic leukemia.

@en

P1476

Overexpression of lymphoid enh ...... acute lymphoblastic leukemia.

@en

P2093

H-P Shen

http://www.w3.org/2001/XMLSchema#string

H-Z Zhao

http://www.w3.org/2001/XMLSchema#string

J-Y Zhang

http://www.w3.org/2001/XMLSchema#string

M Jia

http://www.w3.org/2001/XMLSchema#string

S-S Li

http://www.w3.org/2001/XMLSchema#string

Y-M Tang

http://www.w3.org/2001/XMLSchema#string

Y-P Cheng

http://www.w3.org/2001/XMLSchema#string

Z-B Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Wnt/beta-catenin signaling in development and disease

Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.

Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.

A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia

WNT signalling and haematopoiesis: a WNT-WNT situation.

Diversity of LEF/TCF action in development and disease.

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.

IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.

P304

631-640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJLH.12375

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25955539

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.

about

P2860

P2860

Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921